Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats

Tobacco smoking is the cause of 20% of Canadian deaths per year. Nicotine vaccines present a promising alternative to traditional smoking cessation products, but to date, no vaccine has been able to move through all phases of clinical trials. We have previously demonstrated that the AFPL1-conjugate...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliva, Reynaldo, Fraleigh, Nya L., Lewicky, Jordan D., Fariñas, Mildrey, Hernández, Tamara, Martel, Alexandrine L., Navarro, Ingrid, Dagmar, García-Rivera, Acevedo, Reinaldo, Le, Hoang-Thanh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955701/
https://www.ncbi.nlm.nih.gov/pubmed/31771151
http://dx.doi.org/10.3390/pharmaceutics11120626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955701/
https://www.ncbi.nlm.nih.gov/pubmed/31771151
http://dx.doi.org/10.3390/pharmaceutics11120626

Ejemplares similares